[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

COVID-19 Impact on Global NGS Informatics and Clinical Genomics Market Size, Status and Forecast 2020-2026

July 2020 | 98 pages | ID: CB99E12B4FA4EN
QYResearch

US$ 3,900.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Clinical informatics tools enable the translation of next-generation sequencing and array data into clinically meaningful information.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the NGS Informatics and Clinical Genomics market in 2020.

COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.

The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.

This report also analyses the impact of Coronavirus COVID-19 on the NGS Informatics and Clinical Genomics industry.

Based on our recent survey, we have several different scenarios about the NGS Informatics and Clinical Genomics YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of NGS Informatics and Clinical Genomics will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global NGS Informatics and Clinical Genomics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global NGS Informatics and Clinical Genomics market in terms of revenue.

Players, stakeholders, and other participants in the global NGS Informatics and Clinical Genomics market will be able to gain the upper hand as they use the report as a powerful resource. For this version of the report, the segmental analysis focuses on revenue and forecast by each application segment in terms of revenue and forecast by each type segment in terms of revenue for the period 2015-2026.
Regional and Country-level Analysis
The report offers an exhaustive geographical analysis of the global NGS Informatics and Clinical Genomics market, covering important regions, viz, North America, Europe, China, Japan, Southeast Asia, India and Central & South America. It also covers key countries (regions), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by each application segment in terms of revenue for the period 2015-2026.

Competition Analysis

In the competitive analysis section of the report, leading as well as prominent players of the global NGS Informatics and Clinical Genomics market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global NGS Informatics and Clinical Genomics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global NGS Informatics and Clinical Genomics market.

The following players are covered in this report:
  • 2bPrecise
  • Epic Systems
  • Flatiron Health
  • GenomOncology
  • Illumina
  • IBM
  • Koninklijke Philips
  • QIAGEN
  • SOPHiA GENETICS
NGS Informatics and Clinical Genomics Breakdown Data by Type
  • LIMS
  • Data Analysis
  • Interpretation Tools
  • Storage
  • Computing Solutions
NGS Informatics and Clinical Genomics Breakdown Data by Application
  • Academics and Research Institutes
  • Biopharmaceutical Industry
  • Diagnostic Industry
  • Government Agencies
  • Hospitals and Clinics
1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by NGS Informatics and Clinical Genomics Revenue
1.4 Market Analysis by Type
  1.4.1 Global NGS Informatics and Clinical Genomics Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 LIMS
  1.4.3 Data Analysis
  1.4.4 Interpretation Tools
  1.4.5 Storage
  1.4.6 Computing Solutions
1.5 Market by Application
  1.5.1 Global NGS Informatics and Clinical Genomics Market Share by Application: 2020 VS 2026
  1.5.2 Academics and Research Institutes
  1.5.3 Biopharmaceutical Industry
  1.5.4 Diagnostic Industry
  1.5.5 Government Agencies
  1.5.6 Hospitals and Clinics
1.6 Coronavirus Disease 2019 (Covid-19): NGS Informatics and Clinical Genomics Industry Impact
  1.6.1 How the Covid-19 is Affecting the NGS Informatics and Clinical Genomics Industry
    1.6.1.1 NGS Informatics and Clinical Genomics Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and NGS Informatics and Clinical Genomics Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for NGS Informatics and Clinical Genomics Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 NGS Informatics and Clinical Genomics Market Perspective (2015-2026)
2.2 NGS Informatics and Clinical Genomics Growth Trends by Regions
  2.2.1 NGS Informatics and Clinical Genomics Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 NGS Informatics and Clinical Genomics Historic Market Share by Regions (2015-2020)
  2.2.3 NGS Informatics and Clinical Genomics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 NGS Informatics and Clinical Genomics Market Growth Strategy
  2.3.6 Primary Interviews with Key NGS Informatics and Clinical Genomics Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top NGS Informatics and Clinical Genomics Players by Market Size
  3.1.1 Global Top NGS Informatics and Clinical Genomics Players by Revenue (2015-2020)
  3.1.2 Global NGS Informatics and Clinical Genomics Revenue Market Share by Players (2015-2020)
  3.1.3 Global NGS Informatics and Clinical Genomics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global NGS Informatics and Clinical Genomics Market Concentration Ratio
  3.2.1 Global NGS Informatics and Clinical Genomics Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by NGS Informatics and Clinical Genomics Revenue in 2019
3.3 NGS Informatics and Clinical Genomics Key Players Head office and Area Served
3.4 Key Players NGS Informatics and Clinical Genomics Product Solution and Service
3.5 Date of Enter into NGS Informatics and Clinical Genomics Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global NGS Informatics and Clinical Genomics Historic Market Size by Type (2015-2020)
4.2 Global NGS Informatics and Clinical Genomics Forecasted Market Size by Type (2021-2026)

5 NGS INFORMATICS AND CLINICAL GENOMICS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global NGS Informatics and Clinical Genomics Market Size by Application (2015-2020)
5.2 Global NGS Informatics and Clinical Genomics Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America NGS Informatics and Clinical Genomics Market Size (2015-2020)
6.2 NGS Informatics and Clinical Genomics Key Players in North America (2019-2020)
6.3 North America NGS Informatics and Clinical Genomics Market Size by Type (2015-2020)
6.4 North America NGS Informatics and Clinical Genomics Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe NGS Informatics and Clinical Genomics Market Size (2015-2020)
7.2 NGS Informatics and Clinical Genomics Key Players in Europe (2019-2020)
7.3 Europe NGS Informatics and Clinical Genomics Market Size by Type (2015-2020)
7.4 Europe NGS Informatics and Clinical Genomics Market Size by Application (2015-2020)

8 CHINA

8.1 China NGS Informatics and Clinical Genomics Market Size (2015-2020)
8.2 NGS Informatics and Clinical Genomics Key Players in China (2019-2020)
8.3 China NGS Informatics and Clinical Genomics Market Size by Type (2015-2020)
8.4 China NGS Informatics and Clinical Genomics Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan NGS Informatics and Clinical Genomics Market Size (2015-2020)
9.2 NGS Informatics and Clinical Genomics Key Players in Japan (2019-2020)
9.3 Japan NGS Informatics and Clinical Genomics Market Size by Type (2015-2020)
9.4 Japan NGS Informatics and Clinical Genomics Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia NGS Informatics and Clinical Genomics Market Size (2015-2020)
10.2 NGS Informatics and Clinical Genomics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia NGS Informatics and Clinical Genomics Market Size by Type (2015-2020)
10.4 Southeast Asia NGS Informatics and Clinical Genomics Market Size by Application (2015-2020)

11 INDIA

11.1 India NGS Informatics and Clinical Genomics Market Size (2015-2020)
11.2 NGS Informatics and Clinical Genomics Key Players in India (2019-2020)
11.3 India NGS Informatics and Clinical Genomics Market Size by Type (2015-2020)
11.4 India NGS Informatics and Clinical Genomics Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America NGS Informatics and Clinical Genomics Market Size (2015-2020)
12.2 NGS Informatics and Clinical Genomics Key Players in Central & South America (2019-2020)
12.3 Central & South America NGS Informatics and Clinical Genomics Market Size by Type (2015-2020)
12.4 Central & South America NGS Informatics and Clinical Genomics Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 2bPrecise
  13.1.1 2bPrecise Company Details
  13.1.2 2bPrecise Business Overview and Its Total Revenue
  13.1.3 2bPrecise NGS Informatics and Clinical Genomics Introduction
  13.1.4 2bPrecise Revenue in NGS Informatics and Clinical Genomics Business (2015-2020))
  13.1.5 2bPrecise Recent Development
13.2 Epic Systems
  13.2.1 Epic Systems Company Details
  13.2.2 Epic Systems Business Overview and Its Total Revenue
  13.2.3 Epic Systems NGS Informatics and Clinical Genomics Introduction
  13.2.4 Epic Systems Revenue in NGS Informatics and Clinical Genomics Business (2015-2020)
  13.2.5 Epic Systems Recent Development
13.3 Flatiron Health
  13.3.1 Flatiron Health Company Details
  13.3.2 Flatiron Health Business Overview and Its Total Revenue
  13.3.3 Flatiron Health NGS Informatics and Clinical Genomics Introduction
  13.3.4 Flatiron Health Revenue in NGS Informatics and Clinical Genomics Business (2015-2020)
  13.3.5 Flatiron Health Recent Development
13.4 GenomOncology
  13.4.1 GenomOncology Company Details
  13.4.2 GenomOncology Business Overview and Its Total Revenue
  13.4.3 GenomOncology NGS Informatics and Clinical Genomics Introduction
  13.4.4 GenomOncology Revenue in NGS Informatics and Clinical Genomics Business (2015-2020)
  13.4.5 GenomOncology Recent Development
13.5 Illumina
  13.5.1 Illumina Company Details
  13.5.2 Illumina Business Overview and Its Total Revenue
  13.5.3 Illumina NGS Informatics and Clinical Genomics Introduction
  13.5.4 Illumina Revenue in NGS Informatics and Clinical Genomics Business (2015-2020)
  13.5.5 Illumina Recent Development
13.6 IBM
  13.6.1 IBM Company Details
  13.6.2 IBM Business Overview and Its Total Revenue
  13.6.3 IBM NGS Informatics and Clinical Genomics Introduction
  13.6.4 IBM Revenue in NGS Informatics and Clinical Genomics Business (2015-2020)
  13.6.5 IBM Recent Development
13.7 Koninklijke Philips
  13.7.1 Koninklijke Philips Company Details
  13.7.2 Koninklijke Philips Business Overview and Its Total Revenue
  13.7.3 Koninklijke Philips NGS Informatics and Clinical Genomics Introduction
  13.7.4 Koninklijke Philips Revenue in NGS Informatics and Clinical Genomics Business (2015-2020)
  13.7.5 Koninklijke Philips Recent Development
13.8 QIAGEN
  13.8.1 QIAGEN Company Details
  13.8.2 QIAGEN Business Overview and Its Total Revenue
  13.8.3 QIAGEN NGS Informatics and Clinical Genomics Introduction
  13.8.4 QIAGEN Revenue in NGS Informatics and Clinical Genomics Business (2015-2020)
  13.8.5 QIAGEN Recent Development
13.9 SOPHiA GENETICS
  13.9.1 SOPHiA GENETICS Company Details
  13.9.2 SOPHiA GENETICS Business Overview and Its Total Revenue
  13.9.3 SOPHiA GENETICS NGS Informatics and Clinical Genomics Introduction
  13.9.4 SOPHiA GENETICS Revenue in NGS Informatics and Clinical Genomics Business (2015-2020)
  13.9.5 SOPHiA GENETICS Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

LIST OF TABLES

Table 1. NGS Informatics and Clinical Genomics Key Market Segments
Table 2. Key Players Covered: Ranking by NGS Informatics and Clinical Genomics Revenue
Table 3. Ranking of Global Top NGS Informatics and Clinical Genomics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global NGS Informatics and Clinical Genomics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of LIMS
Table 6. Key Players of Data Analysis
Table 7. Key Players of Interpretation Tools
Table 8. Key Players of Storage
Table 9. Key Players of Computing Solutions
Table 10. COVID-19 Impact Global Market: (Four NGS Informatics and Clinical Genomics Market Size Forecast Scenarios)
Table 11. Opportunities and Trends for NGS Informatics and Clinical Genomics Players in the COVID-19 Landscape
Table 12. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 13. Key Regions/Countries Measures against Covid-19 Impact
Table 14. Proposal for NGS Informatics and Clinical Genomics Players to Combat Covid-19 Impact
Table 15. Global NGS Informatics and Clinical Genomics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 16. Global NGS Informatics and Clinical Genomics Market Size by Regions (US$ Million): 2020 VS 2026
Table 17. Global NGS Informatics and Clinical Genomics Market Size by Regions (2015-2020) (US$ Million)
Table 18. Global NGS Informatics and Clinical Genomics Market Share by Regions (2015-2020)
Table 19. Global NGS Informatics and Clinical Genomics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 20. Global NGS Informatics and Clinical Genomics Market Share by Regions (2021-2026)
Table 21. Market Top Trends
Table 22. Key Drivers: Impact Analysis
Table 23. Key Challenges
Table 24. NGS Informatics and Clinical Genomics Market Growth Strategy
Table 25. Main Points Interviewed from Key NGS Informatics and Clinical Genomics Players
Table 26. Global NGS Informatics and Clinical Genomics Revenue by Players (2015-2020) (Million US$)
Table 27. Global NGS Informatics and Clinical Genomics Market Share by Players (2015-2020)
Table 28. Global Top NGS Informatics and Clinical Genomics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NGS Informatics and Clinical Genomics as of 2019)
Table 29. Global NGS Informatics and Clinical Genomics by Players Market Concentration Ratio (CR5 and HHI)
Table 30. Key Players Headquarters and Area Served
Table 31. Key Players NGS Informatics and Clinical Genomics Product Solution and Service
Table 32. Date of Enter into NGS Informatics and Clinical Genomics Market
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global NGS Informatics and Clinical Genomics Market Size by Type (2015-2020) (Million US$)
Table 35. Global NGS Informatics and Clinical Genomics Market Size Share by Type (2015-2020)
Table 36. Global NGS Informatics and Clinical Genomics Revenue Market Share by Type (2021-2026)
Table 37. Global NGS Informatics and Clinical Genomics Market Size Share by Application (2015-2020)
Table 38. Global NGS Informatics and Clinical Genomics Market Size by Application (2015-2020) (Million US$)
Table 39. Global NGS Informatics and Clinical Genomics Market Size Share by Application (2021-2026)
Table 40. North America Key Players NGS Informatics and Clinical Genomics Revenue (2019-2020) (Million US$)
Table 41. North America Key Players NGS Informatics and Clinical Genomics Market Share (2019-2020)
Table 42. North America NGS Informatics and Clinical Genomics Market Size by Type (2015-2020) (Million US$)
Table 43. North America NGS Informatics and Clinical Genomics Market Share by Type (2015-2020)
Table 44. North America NGS Informatics and Clinical Genomics Market Size by Application (2015-2020) (Million US$)
Table 45. North America NGS Informatics and Clinical Genomics Market Share by Application (2015-2020)
Table 46. Europe Key Players NGS Informatics and Clinical Genomics Revenue (2019-2020) (Million US$)
Table 47. Europe Key Players NGS Informatics and Clinical Genomics Market Share (2019-2020)
Table 48. Europe NGS Informatics and Clinical Genomics Market Size by Type (2015-2020) (Million US$)
Table 49. Europe NGS Informatics and Clinical Genomics Market Share by Type (2015-2020)
Table 50. Europe NGS Informatics and Clinical Genomics Market Size by Application (2015-2020) (Million US$)
Table 51. Europe NGS Informatics and Clinical Genomics Market Share by Application (2015-2020)
Table 52. China Key Players NGS Informatics and Clinical Genomics Revenue (2019-2020) (Million US$)
Table 53. China Key Players NGS Informatics and Clinical Genomics Market Share (2019-2020)
Table 54. China NGS Informatics and Clinical Genomics Market Size by Type (2015-2020) (Million US$)
Table 55. China NGS Informatics and Clinical Genomics Market Share by Type (2015-2020)
Table 56. China NGS Informatics and Clinical Genomics Market Size by Application (2015-2020) (Million US$)
Table 57. China NGS Informatics and Clinical Genomics Market Share by Application (2015-2020)
Table 58. Japan Key Players NGS Informatics and Clinical Genomics Revenue (2019-2020) (Million US$)
Table 59. Japan Key Players NGS Informatics and Clinical Genomics Market Share (2019-2020)
Table 60. Japan NGS Informatics and Clinical Genomics Market Size by Type (2015-2020) (Million US$)
Table 61. Japan NGS Informatics and Clinical Genomics Market Share by Type (2015-2020)
Table 62. Japan NGS Informatics and Clinical Genomics Market Size by Application (2015-2020) (Million US$)
Table 63. Japan NGS Informatics and Clinical Genomics Market Share by Application (2015-2020)
Table 64. Southeast Asia Key Players NGS Informatics and Clinical Genomics Revenue (2019-2020) (Million US$)
Table 65. Southeast Asia Key Players NGS Informatics and Clinical Genomics Market Share (2019-2020)
Table 66. Southeast Asia NGS Informatics and Clinical Genomics Market Size by Type (2015-2020) (Million US$)
Table 67. Southeast Asia NGS Informatics and Clinical Genomics Market Share by Type (2015-2020)
Table 68. Southeast Asia NGS Informatics and Clinical Genomics Market Size by Application (2015-2020) (Million US$)
Table 69. Southeast Asia NGS Informatics and Clinical Genomics Market Share by Application (2015-2020)
Table 70. India Key Players NGS Informatics and Clinical Genomics Revenue (2019-2020) (Million US$)
Table 71. India Key Players NGS Informatics and Clinical Genomics Market Share (2019-2020)
Table 72. India NGS Informatics and Clinical Genomics Market Size by Type (2015-2020) (Million US$)
Table 73. India NGS Informatics and Clinical Genomics Market Share by Type (2015-2020)
Table 74. India NGS Informatics and Clinical Genomics Market Size by Application (2015-2020) (Million US$)
Table 75. India NGS Informatics and Clinical Genomics Market Share by Application (2015-2020)
Table 76. Central & South America Key Players NGS Informatics and Clinical Genomics Revenue (2019-2020) (Million US$)
Table 77. Central & South America Key Players NGS Informatics and Clinical Genomics Market Share (2019-2020)
Table 78. Central & South America NGS Informatics and Clinical Genomics Market Size by Type (2015-2020) (Million US$)
Table 79. Central & South America NGS Informatics and Clinical Genomics Market Share by Type (2015-2020)
Table 80. Central & South America NGS Informatics and Clinical Genomics Market Size by Application (2015-2020) (Million US$)
Table 81. Central & South America NGS Informatics and Clinical Genomics Market Share by Application (2015-2020)
Table 82. 2bPrecise Company Details
Table 83. 2bPrecise Business Overview
Table 84. 2bPrecise Product
Table 85. 2bPrecise Revenue in NGS Informatics and Clinical Genomics Business (2015-2020) (Million US$)
Table 86. 2bPrecise Recent Development
Table 87. Epic Systems Company Details
Table 88. Epic Systems Business Overview
Table 89. Epic Systems Product
Table 90. Epic Systems Revenue in NGS Informatics and Clinical Genomics Business (2015-2020) (Million US$)
Table 91. Epic Systems Recent Development
Table 92. Flatiron Health Company Details
Table 93. Flatiron Health Business Overview
Table 94. Flatiron Health Product
Table 95. Flatiron Health Revenue in NGS Informatics and Clinical Genomics Business (2015-2020) (Million US$)
Table 96. Flatiron Health Recent Development
Table 97. GenomOncology Company Details
Table 98. GenomOncology Business Overview
Table 99. GenomOncology Product
Table 100. GenomOncology Revenue in NGS Informatics and Clinical Genomics Business (2015-2020) (Million US$)
Table 101. GenomOncology Recent Development
Table 102. Illumina Company Details
Table 103. Illumina Business Overview
Table 104. Illumina Product
Table 105. Illumina Revenue in NGS Informatics and Clinical Genomics Business (2015-2020) (Million US$)
Table 106. Illumina Recent Development
Table 107. IBM Company Details
Table 108. IBM Business Overview
Table 109. IBM Product
Table 110. IBM Revenue in NGS Informatics and Clinical Genomics Business (2015-2020) (Million US$)
Table 111. IBM Recent Development
Table 112. Koninklijke Philips Company Details
Table 113. Koninklijke Philips Business Overview
Table 114. Koninklijke Philips Product
Table 115. Koninklijke Philips Revenue in NGS Informatics and Clinical Genomics Business (2015-2020) (Million US$)
Table 116. Koninklijke Philips Recent Development
Table 117. QIAGEN Business Overview
Table 118. QIAGEN Product
Table 119. QIAGEN Company Details
Table 120. QIAGEN Revenue in NGS Informatics and Clinical Genomics Business (2015-2020) (Million US$)
Table 121. QIAGEN Recent Development
Table 122. SOPHiA GENETICS Company Details
Table 123. SOPHiA GENETICS Business Overview
Table 124. SOPHiA GENETICS Product
Table 125. SOPHiA GENETICS Revenue in NGS Informatics and Clinical Genomics Business (2015-2020) (Million US$)
Table 126. SOPHiA GENETICS Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources

LIST OF FIGURES

Figure 1. Global NGS Informatics and Clinical Genomics Market Share by Type: 2020 VS 2026
Figure 2. LIMS Features
Figure 3. Data Analysis Features
Figure 4. Interpretation Tools Features
Figure 5. Storage Features
Figure 6. Computing Solutions Features
Figure 7. Global NGS Informatics and Clinical Genomics Market Share by Application: 2020 VS 2026
Figure 8. Academics and Research Institutes Case Studies
Figure 9. Biopharmaceutical Industry Case Studies
Figure 10. Diagnostic Industry Case Studies
Figure 11. Government Agencies Case Studies
Figure 12. Hospitals and Clinics Case Studies
Figure 13. NGS Informatics and Clinical Genomics Report Years Considered
Figure 14. Global NGS Informatics and Clinical Genomics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 15. Global NGS Informatics and Clinical Genomics Market Share by Regions: 2020 VS 2026
Figure 16. Global NGS Informatics and Clinical Genomics Market Share by Regions (2021-2026)
Figure 17. Porter's Five Forces Analysis
Figure 18. Global NGS Informatics and Clinical Genomics Market Share by Players in 2019
Figure 19. Global Top NGS Informatics and Clinical Genomics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in NGS Informatics and Clinical Genomics as of 2019
Figure 20. The Top 10 and 5 Players Market Share by NGS Informatics and Clinical Genomics Revenue in 2019
Figure 21. North America NGS Informatics and Clinical Genomics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Europe NGS Informatics and Clinical Genomics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. China NGS Informatics and Clinical Genomics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Japan NGS Informatics and Clinical Genomics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Southeast Asia NGS Informatics and Clinical Genomics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. India NGS Informatics and Clinical Genomics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Central & South America NGS Informatics and Clinical Genomics Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. 2bPrecise Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. 2bPrecise Revenue Growth Rate in NGS Informatics and Clinical Genomics Business (2015-2020)
Figure 30. Epic Systems Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Epic Systems Revenue Growth Rate in NGS Informatics and Clinical Genomics Business (2015-2020)
Figure 32. Flatiron Health Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Flatiron Health Revenue Growth Rate in NGS Informatics and Clinical Genomics Business (2015-2020)
Figure 34. GenomOncology Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. GenomOncology Revenue Growth Rate in NGS Informatics and Clinical Genomics Business (2015-2020)
Figure 36. Illumina Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Illumina Revenue Growth Rate in NGS Informatics and Clinical Genomics Business (2015-2020)
Figure 38. IBM Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. IBM Revenue Growth Rate in NGS Informatics and Clinical Genomics Business (2015-2020)
Figure 40. Koninklijke Philips Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Koninklijke Philips Revenue Growth Rate in NGS Informatics and Clinical Genomics Business (2015-2020)
Figure 42. QIAGEN Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. QIAGEN Revenue Growth Rate in NGS Informatics and Clinical Genomics Business (2015-2020)
Figure 44. SOPHiA GENETICS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. SOPHiA GENETICS Revenue Growth Rate in NGS Informatics and Clinical Genomics Business (2015-2020)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed


More Publications